NRx Pharmaceuticals shares gained after the company said it would buy California psychiatry clinic Kadima Neuropsychiatry Institute. The stock rose Thursday to $2.92, reaching a six-month high. Shares ...

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year from ...

Travelzoo's stock has tripled since summer, and key indicators suggest potential for further upside. Click here to find out ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Schwab U.S. Dividend Equity's top 10 holdings posted a weak 3% revenue growth in 2024, compared to 24.1% for S&P 500's top 10 ...

We recently published a list of the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds. In this article, we are ...

Alibaba stock was lower Thursday after it announced a $1.7 billion deal to sell Sun Art, a hypermarket operator in China.

Summary The Chart of the Day belongs to the eye care therapeutics company Tarsus Pharmaceuticals TARS. I found the stock by ...

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Big changes to the S&P 500 are taking giant tech stocks down a notch. And that means big changes for ETF investors.

Argus has recently raised Teva Pharmaceutical Industries Ltd (TEVA) stock to Buy rating, as announced on July 10, 2024, according to Finviz. Earlier, on March 8, 2024, JP Morgan had raised the stock ...

Suzlon Energy(numbers of share traded: 6.79 crore), YES Bank(numbers of share traded: 6.70 crore), Filatex Fashions(numbers ...